XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.38

-2.5%

11:25 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (16480)	11/23/2003 1:42:39 PM
From: aknahow	Read Replies (2) of 17367

Nice find. Like the fact that they mentioned expecting to treat the 208. Good that the FDA is involved in helping to keep things from going too fast. After all only kids are involved. Now if old people were involved things might be different. Sure Neuprex appears safe but waiting for the FDA decision will make it even more so. In fact they may turn down the higher dose, or suggest something less than what the clinic wants. that would assure safety. <g> Now tell me why Xoma could not just have told everyone the potential number of subjects? Am more impressed now than before as I never thought probe would mean more than ten or twenty subjects.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next